U.S. market Closed. Opens in 11 hours 28 minutes

ADMA | ADMA Biologics, Inc. Stock Fundamentals

(Stock Exchange: NASDAQ)
Analyzing fundamentals for ADMA we got that it has average fundamentals where Valuation is considered to be significantly overvalued, Profitability is poor, Growth is good and Health is strong.

Valuation (24%)

Company Industry
P/E Ratio (TTM) 120.86 -16.22
PEG Ratio (TTM) 1.73 -1.41
P/S Ratio (TTM) 12.77 48.82
P/B Ratio (TTM) 22.33 21.13
P/FCF Ratio (TTM) 63.77 9.38
Price to 5YR AVG Earnings Ratio -28.02 -0.21
Price to 5YR AVG FCF Ratio -54.03 -7.10

Profitability (50%)

Company Industry
ROA (TTM) 9.24% -3.10%
ROE (TTM) 22.14% 24.21%
Net Profit Margin (TTM) 10.53% -1,069.78%
ROIC 5YR AVG -21.41% 16.50%

Growth (63%)

4QTR AVG 3YR AVG 5YR AVG
EPS -91.42% 23.55% 33.98%
Revenue 15.86% 69.45% 73.26%
Net Income -91.66% -12.25% 5.85%
Cash Flow 597.50% -21.87% 19.25%

Health (67%)

Company Industry
Current Ratio (TTM) 6.87 5.75
Quick Ratio (TTM) 2.80 5.47
D/E Ratio (TTM) 0.70 -15.13
Interest Coverage (TTM) 4.16 3.59
Piotroski F-Score 5 5
Altman Z-Score 14.03 13.47
LTL to 5YR AVG FCF -1.67 0.20
Shares Outstanding Growth 5YR AVG 39.15% 118.86%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙